Skip to main content
Premium Trial:

Request an Annual Quote

Califf Nomination Moves Ahead, For Now

The Senate Health, Education, Labor, and Pensions Committee voted unanimously this week to approve Robert Califf as the commissioner of the Food and Drug Administration, the New York Times reports. However, it adds that Califf, a Duke University cardiologist, still has some hurdles to overcome before securing that spot.

Califf was nominated to the post in September, following the departure of Margaret Hamburg. While at Duke, he ran the school's $200 million clinical research institute, which is financed by both government grants and private sector funds. He has also served as a consultant to drug companies, the Times says. This has suggested to some critics, including Vermont Senator Bernie Sanders, a Democratic presidential candidate, and Senator Elizabeth Warren (D-Mass.), that he might be too close to the industry FDA regulates.

Senator Lisa Murkowski (R-Alaska) has also said that she will put a hold on his candidacy over the agency's approval of genetically modified salmon, the Times adds. Alaska is a major producer of salmon.

Vermont Senator Bernie Sanders, a Democratic presidential candidate, has also indicated he may put a hold on Califf's candidacy, saying that he hasn't done enough to curtail rising drug prices.

Murkowski, Warren, and Sanders are members of the committee, which approved the nomination by unanimous voice vote, the Times notes. Murkowski voted for Califf's nomination as her hold can be placed after the matter leaves the committee.

Califf addressed some of Warren's concerns in a letter, Stat News notes. In a statement, she says she'd looked into Califf's record and is "satisfied that he has conducted himself with integrity as an academic researcher," it adds.

Sanders was not present at the committee vote, and he'd asked that his no vote be recorded, but the committee opted for a voice vote.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.